- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02145780
Polyphenols and Overfeeding (Poly-Nut)
Polyphenols: Protection From Overfeeding-induced Insulin Resistance?
Obesity is a complex and multifactorial disease representing a major public health challenge. Indeed, overweight and obese people carry a major risk of developing insulin resistance and type 2 diabetes mellitus. It has been demonstrated that polyphenols could be used to counteract some of the mechanisms involved in the generation of insulin resistance. The model of overfeeding represents a very good study model of the metabolic complications of obesity, since it has been shown to induce a transient state of insulin resistance in the human.
The purpose of this research is to study the effects of a overfeeding (+50% of daily caloric needs over 31 days) with or without polyphenols supplementation (2g/days over 31 days) on insulin sensitivity measured in the setting of a hyperinsulinemic euglycemic clamp and on post prandial partitioning of exogenous lipids after a test meal.
During 31 days, the volunteers will consume chocolate bars, chips, chocolate breads and cola in addition to their usual diet and will be supplemented with 2g of grape polyphenols extract or with placebo.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Pierre-bénite, Frankreich, 69495
- Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Male
- Aged from 18 to 55 years
- Body Mass Index of 23 to 27 kg/m²
- Normal blood pressure
- Fasting glycemia < 7 mmol/L
- CRPus < 10mg/L
- Triglycerides ≤ 3mmol/L
Exclusion Criteria:
- Medical or surgical history which may affect the results (renal -cardiovascular - hepatic- endocrine-inflammatory diseases)
- Subjects under treatment which may interfere with the measured parameters
- Eating disorder
- Intensive sportive activity
- Dairy products allergy or intolerance
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Vervierfachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: 2g of grape polyphenol extract supplement
Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.
|
Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.
|
Placebo-Komparator: 2g of placebo (lactose)
Men will have to consume daily 2g of placebo during the 31 days of overfeeding.
|
Men will have to consume daily 2g of placebo during the 31 days of overfeeding.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Peripheral insulin sensitivity
Zeitfenster: During 31 days
|
Volunteers will have peripheral and hepatic insulin sensitivity determined by using a two-stage hyperinsulinemic euglycemic clamp with stable isotopically labeled tracer infusion.
|
During 31 days
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Hepatic insulin sensitivity
Zeitfenster: before and after the 31 days of overfeeding
|
Endogenous glucose production (EGP) will be determined during the last 30 minutes of the low-dose insulin infusion.
|
before and after the 31 days of overfeeding
|
Change in genes expression in adipose and muscle tissues
Zeitfenster: Before and after the 31 days of overfeeding
|
RT-PCR
|
Before and after the 31 days of overfeeding
|
Anthropometry, Fat quantification and Abdominal fat distribution
Zeitfenster: During 31 days
|
Weight, height, waist and hip circumferences, fat mass using dual x-ray absorptiometry (DEXA) and abdominal fat distribution using resonance magnetic imaging (RMI).
|
During 31 days
|
Fasting and Postprandial partitioning of exogenous lipid
Zeitfenster: Fasting and during all the postprandial period (0-300 minutes)
|
13C enrichment will be measured in blood samples and breath test during a test meal performed before and after the 31 days of overfeeding.
|
Fasting and during all the postprandial period (0-300 minutes)
|
Modification in intestinal microbiota
Zeitfenster: Before and after the 31 days of overfeeding
|
Feces analyses
|
Before and after the 31 days of overfeeding
|
Energy expenditure and substrate oxidation with indirect calorimetry
Zeitfenster: Fasting and during all the postprandial period (0-300 minutes)
|
Energy metabolism will be measured before and after the 31 days of overfeeding.
|
Fasting and during all the postprandial period (0-300 minutes)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Martine LAVILLE, MD, PhD, Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Bartova S, Madrid-Gambin F, Fernandez L, Carayol J, Meugnier E, Segrestin B, Delage P, Vionnet N, Boizot A, Laville M, Vidal H, Marco S, Hager J, Moco S. Grape polyphenols decrease circulating branched chain amino acids in overfed adults. Front Nutr. 2022 Oct 26;9:998044. doi: 10.3389/fnut.2022.998044. eCollection 2022.
- Segrestin B, Delage P, Nemeth A, Seyssel K, Disse E, Nazare JA, Lambert-Porcheron S, Meiller L, Sauvinet V, Chanon S, Simon C, Ratiney H, Beuf O, Pralong F, Yassin NA, Boizot A, Gachet M, Burton-Pimentel KJ, Vidal H, Meugnier E, Vionnet N, Laville M. Polyphenol Supplementation Did Not Affect Insulin Sensitivity and Fat Deposition During One-Month Overfeeding in Randomized Placebo-Controlled Trials in Men and in Women. Front Nutr. 2022 May 9;9:854255. doi: 10.3389/fnut.2022.854255. eCollection 2022.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2013-807
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .